Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed cases of rheumatoid arthritis according to the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) criteria Patients of an either gender with age more than 18 years On stable dose of anti-rheumatoid medication for 4 weeks prior to enrolment in study Ability to provide written informed consent. Willingness to participate in educational sessions and adhere to study protocols. Proficiency in the local language or English to understand educational materials.
Exclusion criteria
Exclusion criteria: I. Severe cognitive impairment or psychiatric conditions that may interfere with study participation. II. Patient suffering from severe chronic illness which may affect the disease outcome/compliance. III. Concurrent participation in other interventional studies related to RA management. IV. Pregnancy or breastfeeding, as these conditions may affect medication regimens and disease activity. V. History of non-adherence to medical appointments or inability to attend follow-up visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean changes in CQR 19 score at week 12 in both groups.Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in CQR 19 score from baseline to week 6, and week 12 in both groups.Timepoint: 0 to 6 weeks and 12 weeks;Change in Disease activity score (DAS) from baseline to week 6 and week 12 in both the groups.Timepoint: 12 weeks;Proportion of patients achieving remission in both the groupsTimepoint: 12 weeks;To study the impact of various sociodemographic variables along with medication adherence on disease activityTimepoint: 12 weeks | — |
Countries
India
Contacts
AIIMS Nagpur